Evidence map›Paper›PMID 35889411›Full record

ArticleMolecules (Basel, Switzerland)2022

Asymmetric AZA-BODIPY with Optical Gain in the Near-Infrared Region.

Tersilla Virgili, Lucia Ganzer, Chiara Botta, Benedetta Maria Squeo, Mariacecilia Pasini

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tersilla VirgiliInstitute for Photonics and Nanotechnologies (IFN), National Research Council-CNR, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.ORCID 0000-0002-8075-0498
Lucia GanzerInstitute for Photonics and Nanotechnologies (IFN), National Research Council-CNR, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.
Chiara BottaIstituto di Scienza e Tecnologie Chimiche (SCITEC), National Research Council-CNR, Via Corti, 20133 Milan, Italy.
Benedetta Maria SqueoIstituto di Scienza e Tecnologie Chimiche (SCITEC), National Research Council-CNR, Via Corti, 20133 Milan, Italy.ORCID 0000-0002-5260-512X
Mariacecilia PasiniIstituto di Scienza e Tecnologie Chimiche (SCITEC), National Research Council-CNR, Via Corti, 20133 Milan, Italy.ORCID 0000-0002-7811-6367
National Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been a lot of interest in the development of organic compounds emitting in the near-infrared (NIR) region due to their stimulating applications, such as biosensing and light detection and ranging (LiDAR). Moreover, a lot of effort has been devoted to finding organic emitters with optical gain in the NIR region for lasing applications. In this paper, we present the ultrafast spectroscopy of an asymmetric AZA-BODIPY molecule that shows relevant photophysical changes moving from a diluted solution to a concentrated solution and to a spin-coated film. The diluted solution and the spin-coated film show a bleaching band and a stimulated emission band in the visible region, while the very concentrated solution displays a broad (150 nm) and long-living (more than 400 ps) optical gain band in the NIR region, centered at 900 nm. Our results pave the way for a new organic laser system in a near-infrared spectral region.

Indexed as

Boron CompoundsSpectrum AnalysisazaBDPBA compoundBoron CompoundsAZA-BODIPYstimulated emissionultrafast spectroscopy

Identifiers

PMID35889411
PMCPMC9318515
OpenAlexW4285732994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.